Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase II Prospective Clinical Trial (GASTO1011)-Reference-Cited by-同舟云学术

Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase II Prospective Clinical Trial (GASTO1011)

Published:2021-09 Issue:5 Volume:11 Page:374-383
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Qiu Bo,Xiong Mai,Luo YiFeng,Li QiWen,Chen NaiBin,Chen Li,Guo SuPing,Wang Bin,Huang XiaoYan,Lin MaoSheng,Hu Nan,Guo JinYu,Liang Ying,Fang Yi,Li JiBin,Yang YunPeng,Huang Yan,Zhang Li,Wang SiYu,Liu Hui^ORCID

Funder

Science and Technology Planning Project of Guangdong Province

Varian Medical Systems

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference40 articles.

1. Cancer burden of major cancers in China: A need for sustainable actions;Cao;Cancer Comm,2020

2. Concurrent chemotherapy and radiation therapy for inoperable locally advanced non-small-cell lung cancer;Rosenzweig;J Clin Oncol,2017

3. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003;Pfister;J Clin Oncol,2004

4. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume;Basaki;Int J Radiat Oncol Biol Phys,2006

5. Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer;De Petris;Med Oncol,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of K^transderived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy;Journal for ImmunoTherapy of Cancer;2024-06

2. Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study;Clinical Cancer Research;2024-04-23

3. Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity;Cancer Treatment Reviews;2024-03

4. Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049);International Journal of Radiation Oncology*Biology*Physics;2023-10

5. Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis;Radiation Oncology;2023-05-22